Autopsy report · NCT00444834

A Study of Controlled-Release Carvedilol Compared to Immediate-Release Carvedilol in Patients With Primary Hypertension

Cause of deathDrug or device supply Automatic label, confidence 0.9, unverified. How labels are made.

“IMP supply”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 month before it started.
Ran for about 1 month before it stopped.
14 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: Egalet Ltd
Sponsor type: Industry
Conditions: Hypertension
Interventions: Carvedilol
Participants: 14
Sites: 2
Countries: Denmark

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.